Molecular Imaging, How Close to Clinical Precision Medicine in Lung, Brain, Prostate and Breast Cancers

Area of Science:

• Oncology
• Medical Imaging
• Translational Medicine

Background:

• Precision medicine offers tailored cancer therapy, surpassing traditional methods by customizing treatment plans.
• Accurate tumor biological information is crucial for effective precision medicine, but traditional biopsies have limitations.
• Molecular imaging presents a noninvasive alternative for visualizing tumor characteristics and guiding treatment decisions.

Purpose of the Study:

• To review the role and clinical applications of molecular imaging in advancing precision cancer medicine.
• To highlight how molecular imaging aids in patient screening, treatment monitoring, and prognosis estimation.
• To discuss current challenges and future directions for molecular imaging in clinical cancer therapy.

Main Methods:

• Review of representative clinical trials and studies involving molecular imaging in cancer patients.
• Analysis of molecular imaging's contribution to personalized treatment strategies and therapeutic target identification.
• Evaluation of molecular imaging's utility in assessing treatment response and pharmacodynamic effects.

Main Results:

• Molecular imaging provides critical, noninvasive data on tumor biology, therapeutic targets, and treatment response.
• Clinical evidence supports molecular imaging's value in patient stratification and monitoring for precision cancer therapy.
• Molecular imaging facilitates a more personalized approach to cancer treatment, improving efficacy and reducing side effects.

Conclusions:

• Molecular imaging is a valuable tool for enhancing precision medicine in oncology.
• Further clinical translation of molecular imaging is essential for optimizing individualized cancer treatment strategies.
• Molecular imaging offers significant potential to improve patient outcomes in precision cancer care.